Active Ingredient Prescribing on computer-generated prescriptions became mandatory for prescribers from 1 February 2021. Most prescribing software has been updated to reflect the new requirement. There is also information and resources for prescribers available from the Safety Commission, including medicines that are excluded from the requirements and medicines for which prescribers are recommended to consider including a brand.
Since its national roll-out, the Pharmacy Guild of Australia has been receiving reports from pharmacists about prescriptions for which there are significant safety concerns. Some of the problems relate to specific software and it is important that prescribers report any identified problems to their software provider.
Some prescriptions are confusing or unclear (e.g. omission of strength) and require clarification from the prescriber before they can be dispensed. Other examples include prescriptions in which the medicine is incomplete (e.g. ‘Insulin 100iu/ml vial’ without specifying the type of insulin). In such cases, delays in the pharmacist clarifying the prescription with the prescriber may have significant consequences for patients.
Pharmacists are reporting prescriptions for multiple ingredients in which the strengths do not correlate with the ingredient. For example, Targin 5/2.5mg appears as naloxone/oxycodone 5/2.5mg rather than oxycodone/naloxone 5/2.5mg.
There are also examples of prescriptions being generated that are not consistent with the recommendations from the Safety Commission. As an example, a prescription for four or more active ingredients (e.g. Bexsero) should be prescribed by brand. Likewise, the Safety Commission recommends for high-risk medicines such as insulin or warfarin that prescribers include a brand on the prescription.
Pharmacists are also reporting that some patients are upset and confused and worried that they have the wrong prescriptions. Prescribers can help allay any concerns when writing the prescription and this can be reinforced when the patient presents to the pharmacy.
If you are issuing an electronic token prescription, information which is entered into the ‘notes section’ when prescribing (eg clarification of brand intention for a combined oral contraceptive or clarification of strength of drug if it is not clear from software) is considered part of the legal prescription and can be used by pharmacists. However, if issuing a paper prescription (even if it is sent via a prescription delivery service) the legislation states that all pertinent information including strength of drug must be printed on the prescription, and as such electronic notes associated are NOT sufficient for the pharmacist to legally dispense the prescription.
The Pharmacy Guild of Australia and the Primary Health Network are encouraging all prescribers and pharmacists to be extra vigilant in checking computer generated prescriptions and communicating with each other and their patients to avoid prescription-related errors and allaying any patient concerns.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Launch of new Australian Guideline for assessing and managing cardiovascular disease risk The 2023 Australian Guideline for assessing and managing cardiovascular disease risk, and associated Australian cardiovascular disease risk calculator (Aus CVD Risk Calculator), will become the new standard of care for the primary prevention of CVD in Australia. This…
At CESPHN we value your feedback and invite you to complete the 2023 stakeholder engagement survey At CESPHN, we value your feedback and invite you to complete the stakeholder engagement survey on our service delivery and communication over the past 12 months. This short survey only takes five minutes and…
CESPHN Healthy Ageing Strategy 2023-28 has been released The Central and Eastern Sydney PHN has developed a Healthy Ageing Strategy to empower older people in our region to live more active and fulfilling lives, enabled by inclusive communities, and supported by integrated person-centred health and social services. Healthy ageing relies…
NSW community urged to be on alert amid rise in listeriosis NSW Health is reminding people who are immunocompromised, pregnant, or aged over 65 years to avoid foods that can cause listeriosis, following several confirmed cases of listeria infection in NSW. Listeriosis infection, which comes from consuming food contaminated with…
CESPHN Primary Health Awards: 2023 Finalists and Winners announced At a packed event last night at the Hazelhurst Arts Centre in Gymea, CESPHN held its annual Primary Health Awards. CESPHN’s multicultural community was reflected in our numerous and diverse submissions. All immensely impressive. The winners, announced at the awards event,…